Literature DB >> 1864491

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

A Fontbonne1, M A Charles, N Thibult, J L Richard, J R Claude, J M Warnet, G E Rosselin, E Eschwège.   

Abstract

The Paris Prospective Study is a long-term, large-scale study of the factors predicting coronary heart disease. The first follow-up examination included, for subjects not known as having diabetes mellitus, a 75 g oral glucose tolerance test with measurement of plasma insulin and glucose levels, fasting and 2 h post-load. Between 1968 and 1973, 6903 men aged 43-54 years were thus examined. Causes of death were ascertained within this group after 15 years of mean follow-up. The baseline variables were tested as predictors of death from coronary heart disease by a Cox regression analysis. Significant independent predictors of coronary heart disease death were: systolic blood pressure, number of cigarettes per day, plasma cholesterol level, and 2 h post-load plasma insulin level when entered as a categorical variable (below or above 452 pmol/l. i.e. the lower limit of the fifth quintile of the distribution). This dichotomization was performed to account for the non-linear univariate distribution of deaths with increasing post-load insulin values. Fasting plasma insulin level was not an independent predictor of death by coronary heart disease over this long-term follow-up. Levels of blood glucose were not significant independent predictors of death by coronary heart disease when plasma insulin levels were included in the model. The same applied to abnormalities of glucose tolerance when the 125 men with known non-insulin-treated diabetes at baseline were added to the group. Under the assumption that hyperinsulinaemia is a marker of insulin resistance, the results are consistent with the hypothesis that insulin resistance is associated with a higher risk of coronary heart disease mortality. However, it is doubtful that circulating insulin per se is a direct cause of arterial complications.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864491     DOI: 10.1007/bf00405009

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Metabolic abnormalities in children of non-insulin dependent diabetics.

Authors:  R D Leslie; H P Volkmann; M Poncher; I Hanning; H Orskov; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

2.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

3.  Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

Authors:  K Pyörälä; E Savolainen; S Kaukola; J Haapakoski
Journal:  Acta Med Scand Suppl       Date:  1985

4.  Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide.

Authors:  E A Nikkilä; T A Miettinen; M R Vesenne; R Pelkonen
Journal:  Lancet       Date:  1965-09-11       Impact factor: 79.321

5.  Increased insulin concentrations in nondiabetic offspring of diabetic parents.

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

6.  Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study.

Authors:  R J Jarrett; M J Shipley
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

7.  Insulin and HDL-cholesterol metabolism.

Authors:  P Fossati; M Romon-Rousseaux
Journal:  Diabete Metab       Date:  1987-07

8.  Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus.

Authors:  K Pyörälä; M Uusitupa; M Laakso; O Siitonen; L Niskanen; T Rönnemaa
Journal:  Diabete Metab       Date:  1987-07

9.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

10.  Insulin insensitivity in offspring of parents with type 2 diabetes mellitus.

Authors:  L T Ho; Z Y Chang; J T Wang; S H Li; Y F Liu; Y D Chen; G M Reaven
Journal:  Diabet Med       Date:  1990-01       Impact factor: 4.359

View more
  37 in total

Review 1.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

2.  Genetic and environmental architecture of the features of the insulin-resistance syndrome.

Authors:  Y Hong; N L Pedersen; K Brismar; U de Faire
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

3.  Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.

Authors:  J W Yarnell; C C Patterson; D Bainton; P M Sweetnam
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

4.  Differentials and Determinants of Syndrome 'X' and its Role as Coronary Risk among Healthy Middle Aged Indian Army Personnel.

Authors:  Rajvir Bhalwar; V C Ohri; B L Somani; A S Kasthuri
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

Authors:  G Piédrola; E Novo; J Serrano-Gotarredona; M L de Teresa; R García-Robles
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

Review 6.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

7.  Insulin and cardiovascular disease: biomarker or association?

Authors:  K A M Jandeleit-Dahm; S P Gray
Journal:  Diabetologia       Date:  2012-09-28       Impact factor: 10.122

8.  Fetal and infant growth and cardiovascular risk factors in women.

Authors:  C H Fall; C Osmond; D J Barker; P M Clark; C N Hales; Y Stirling; T W Meade
Journal:  BMJ       Date:  1995-02-18

Review 9.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

10.  Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; N Thibult; E Eschwège; P Ducimetière
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.